Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- PMID: 32043983
- PMCID: PMC7134694
- DOI: 10.1016/S0140-6736(20)30317-2
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Comment in
-
On the use of corticosteroids for 2019-nCoV pneumonia.Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12. Lancet. 2020. PMID: 32122468 Free PMC article. No abstract available.
-
Corticosteroid use for 2019-nCoV infection: A double-edged sword.Infect Control Hosp Epidemiol. 2020 Oct;41(10):1244-1245. doi: 10.1017/ice.2020.165. Epub 2020 Apr 23. Infect Control Hosp Epidemiol. 2020. PMID: 32321620 Free PMC article. No abstract available.
-
Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.Hong Kong Med J. 2020 Jun;26(3):269-271. doi: 10.12809/hkmj208517. Epub 2020 Jun 5. Hong Kong Med J. 2020. PMID: 32536610 No abstract available.
References
-
- Arabi YM, Mandourah Y, Al-Hameed F. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 2018;197:757–767. - PubMed
-
- WHO . World Health Organization; Geneva: Jan 28, 2020. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected.https://www.who.int/publications-detail/clinical-management-of-severe-ac...
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical